Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
about
Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in ItalyEpidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyHepatitis B virus: where do we stand and what is the next step for eradication?Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.Hepatitis B virus genotype distribution and genotype-specific BCP/preCore substitutions in acute and chronic infections in Argentina.Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.Epidemiological impact of mandatory vaccination against hepatitis B in Italian young adults.Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation.Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town.Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014).Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia.Clinical, epidemiological and virological features of acute hepatitis B in Italy.Presence of anti-HBs antibodies in blood donors 18-22 years after vaccination and implications for the selection of candidates for plasmapheresis for the production of hyperimmune plasma.Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region.Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.Unsolved problems and future perspectives of hepatitis B virus vaccination.Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains.Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.Unawareness of HBV infection among inpatients in a Southern Italian hospital
P2860
Q33461990-8D815DB7-7207-4AF7-AE02-BB5157E81DAAQ33801300-5F216D3A-7496-4332-98E2-9B39415D683DQ33958764-A313AEF8-0E94-4225-A6E6-D624EB77C190Q34329062-B96AAA06-6EC4-468F-86D3-EDC86A8A53E1Q35231194-65D5438D-1924-4DBE-B25C-45FD4538E082Q35434455-20B48756-675E-42EA-BA09-0BA819F54DEAQ35603754-D0B6CE3B-604D-4CEF-B95D-E0F4931A9B06Q35887238-B4330F9D-5758-4897-BC93-E878A548D7B5Q36159994-0D4425FB-33F4-43AB-9959-3C87B4B740BAQ36838969-4D97EE30-6418-4FCB-BE4D-E950DB61F7F5Q37478352-CCBAA6A3-C825-48FE-92D7-B0018D10F939Q38293584-4D1A509A-647A-4BC6-BCD8-673E4EA46372Q38793117-5392C909-3326-4797-9C8B-B9E8131F5618Q39415844-31F4E7C5-3DEB-48DF-94AB-CBFA9276A010Q39494166-5CF9D126-5FCB-488E-953A-4F2215E3C933Q39893157-71A68CF4-EC72-4BE1-9772-B4C666E5ACCAQ40571829-7605E02A-9F1E-4964-825C-2663421CE416Q41474751-197BA5DF-2C09-43DB-A32C-75F0A0E8B452Q41855000-FE92A582-3853-4640-BDD1-C95BB713EE64Q42209108-31400339-1049-451C-B887-03FBAF5AB488Q42232465-FF46CC9C-2FBC-48F9-B6A1-77D324266F0BQ42412334-551FBDE9-0162-411F-AAF7-8B484509B7A2Q45323887-1FCC2213-440B-4B0B-8D18-133F5E28D5EEQ45769211-B990BF7F-9295-4339-8A48-114524C1179EQ51030867-931D9880-FEE6-4F3C-96E6-7E2A6432E34DQ57557330-4E97508C-C206-4EFA-917F-C381F09DF45F
P2860
Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@en
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@nl
type
label
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@en
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@nl
prefLabel
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@en
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@nl
P2093
P2860
P356
P1476
Acute hepatitis B 14 years aft ...... ement and emerging challenges.
@en
P2093
Alfonso Mele
Andrea Mariano
Antonio Ferro
Bianca Borrini
Carla Zotti
Emanuela Balocchini
Enea Spada
Filippo Curtale
National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group
Renato Pizzuti
P2860
P304
P356
10.1086/528687
P407
P577
2008-03-01T00:00:00Z